Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

PRESIDENT AND FELLOWS OF HARVARD COLLEGE

UEI: UNVDZNFA8R29CAGE: 3KFQ9

PRESIDENT AND FELLOWS OF HARVARD COLLEGE is a federal contractor, registered under UEI UNVDZNFA8R29 and CAGE code 3KFQ9. It has been awarded $3,147,436,500 in federal contracts. Primary work spans Unknown NAICS, Research and Development in Biotechnology (except Nanobiotechnology), and Other NAICS codes (21 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

UNVDZNFA8R29

CAGE Code

3KFQ9

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Educational InstitutionNon-Profit OrganizationPrivate University or College

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)
541720Research and Development in the Social Sciences and Humanities
923110Administration of Education Programs(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Harvard College President & Fellows of specializes in advanced research, leadership development, and scientific support services for federal agencies, leveraging academic rigor to deliver mission-critical solutions. Their core capabilities include biostatistics, epidemiological analysis, data scienc...

Harvard College President & Fellows of specializes in advanced research, leadership development, and scientific support services for federal agencies, leveraging academic rigor to deliver mission-critical solutions. Their core capabilities include biostatistics, epidemiological analysis, data science, and bioinformatics for life sciences research, particularly in cancer epidemiology, mortality risk modeling, and health outcomes. They provide high-level professional training in meta-leadership and management development, designed for senior federal executives and specialized cadres, integrating evidence-based pedagogy with real-world policy challenges. Technical expertise spans research design, large-scale data analysis, database architecture, and scientific collaboration frameworks across physical, engineering, and social sciences, with a distinct focus on translating academic inquiry into actionable government outcomes. The contractor maintains a strong, sustained relationship with the Department of Veterans Affairs, delivering bioinformatics support, statistical analysis, and leadership training tailored to veteran health systems. They also serve the Department of Health and Human Services with cutting-edge research in cancer epidemiology and public health trends, and the Department of Education with executive development programs aimed at improving educational leadership capacity. These engagements reflect a pattern of deep, trust-based partnerships centered on evidence-based decision-making and workforce capacity building. Their primary industry focus lies in professional and management development training, research and development in life sciences, and the administration of education programs. They position themselves at the intersection of academia and federal mission delivery, offering specialized expertise in biotechnology, epidemiology, and leadership science—areas where rigorous methodology meets public sector urgency. As an entity structured under 8H with headquarters in Boston, MA, the contractor operates as a prestigious academic institution engaged in federal contracting without formal government certifications. Their geographic presence is anchored in New England, but their impact extends nationally through federally funded research and training initiatives.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

2,143

All time

Active

170

Currently performing

Completed

1,972

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)$60.1M1.9%
Awards by Agency Over Time
Awards by Place of Performance

Compete with PRESIDENT AND FELLOWS OF HARVARD COLLEGE

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PRESIDENT AND FELLOWS OF HARVARD COLLEGE

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PRESIDENT AND FELLOWS OF HARVARD COLLEGE's top NAICS codes and agencies

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is establishing the Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This continuous, open announcement seeks to build a network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation medical defense solutions. The program focuses on two primary pillars: host-targeted resilience, which targets critical host systems like neurological and respiratory pathways to enhance physiological protection, and threat-targeted neutralization, which focuses on broad-spectrum countermeasures for prophylaxis and acute treatment. Priority is given to candidates designed for austere environments, featuring environmental stability without cold-chain reliance and simplified administration routes such as oral or intranasal delivery. The government is inviting two types of participants: MCM Development Collaborators, ranging from Phase I products through FDA licensure, and MCM Development Support Collaborators, such as CROs and CDMOs specializing in preclinical testing, cGMP manufacturing, and regulatory submissions. Interested parties must submit a white paper of no more than five pages detailing their product descriptions, efficacy data, regulatory status, and manufacturing capabilities. Acceptance into the PBA enables the subsequent award of project orders under the authority of 10 U.S.C sections 4021, 4022, and 4023. These agreements are not subject to the Competition in Contracting Act of 1984. All prospective awardees must be registered in the System for Award Management (SAM) database to receive payment.
W6QK Acc-Apg

POSTED

about 16 hours ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
DNA Sequencing Service
Solicitation # 75N98027Q00090
The National Institutes of Health (NIH) is soliciting a Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract for high-throughput DNA sequencing services, including Sanger DNA sequencing and whole-plasmid sequencing. The scope of work involves processing plasmid DNA, genomic DNA, and PCR-generated material, with requirements for PCR amplification, product purification, and DNA normalization. The contractor is responsible for providing all sample collection and shipping materials, maintaining strict confidentiality of sequencing data, and retaining DNA samples for at least 180 days post-sequencing. Deliverables include specific electronic file formats such as .ab1, .fasta, and raw FASTQ data, alongside a Monthly Status Report submitted to the Contracting Officer's Representative (COR). The contract spans a five-year period from January 4, 2027, to January 3, 2032, with a total estimated value ranging from $184,200.00 to $958,584.20. Performance and delivery are centered at the NIEHS facility in Research Triangle Park, North Carolina. Award selection will be based on a best value tradeoff, where technical capability and past performance are weighted more heavily than price. Technical evaluations will focus on sequencing capability, personnel qualifications, quality assurance/control, and data management. The acquisition is not set aside for small businesses and falls under NAICS code 541714.
National Institutes Of Health Olao

POSTED

about 16 hours ago

DEADLINE

in 19 days
View Details
NAICS: 541714
New
Federal
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Solicitation # FDABAA-27-00123
The FY27 FDA Broad Agency Announcement (FDABAA-27-00123) solicits basic and applied research and development proposals to advance regulatory science and innovation. Managed by the FDA Office of Acquisitions and Grants Services, this solicitation is open to all responsible sources, including small businesses and academic institutions. The program focuses on 22 priority research areas, with recent updates adding specific interests in human tooth enamel evaluation techniques for anticaries dentifrice products and the adoption of Super Intelligence terminology in tobacco and nicotine research per Executive Order 14434. Interested parties must follow a two-tiered submission process consisting of a three-page concept paper and a comprehensive full proposal, which includes a technical volume limited to 50 pages and a detailed cost proposal. All applications must be submitted as searchable PDFs via email by January 22, 2027, at 5:00 PM EST. A virtual BAA Day is scheduled for December 8, 2026, to provide guidance on the application process and FDA priorities. Awards are based on the overall best value to the government, evaluated through a high-level relevance review followed by a technical review by subject matter experts. Successful offerors must comply with Good Manufacturing Practice Regulations (21 CFR Parts 210-211) and other relevant biological or diagnostic standards. Additionally, proposals exceeding $900,000 from non-small businesses require a Small Business Subcontracting Plan. Contractors must also warrant the absence of organizational conflicts of interest and adhere to strict data disclosure and privacy regulations.
FDA Office Of Acq Grant Svcs

POSTED

about 16 hours ago

DEADLINE

in 2 months
View Details
NAICS: 541714
New
Federal
Presolicitation Notice to Sole Source for Experimental Pathology Laboratories, Inc. (EPL)
Solicitation # Presolicitation_NOI_Sole_Source_EPL
The U.S. Environmental Protection Agency, through the Office of the Chief Procurement Officer's Water, Tribal, and Science Division, intends to award a firm-fixed price purchase order for histology and pathology services of maternal and neonatal rodent specimen organs. The work will be performed at the EPA Headquarters in Washington, DC, and focuses on the toxicologic pathology of environmental contaminants, including PFAS, phthalates, air pollutants, and endocrine-disrupting compounds. This acquisition is intended to continue existing larger studies to maintain data integrity and avoid protocol deviations. The EPA intends to sole source this requirement to Experimental Pathology Laboratories, Inc. (EPL) due to their specialized experience with environmental contaminants, compliance with Good Laboratory Practice regulations, and their ability to accept hand-delivered samples as a local vendor. The procurement falls under NAICS code 541714 for Research and Development in Biotechnology and PSC code AZ11. While the agency intends to award to EPL, other responsible sources may submit capability statements, proposals, or quotations by November 30, 2026. The estimated award date is December 3, 2026. All vendors must maintain a public profile in the System for Award Management and utilize the FedConnect portal for contract communications.
Tribal & Science Division Water

POSTED

5 days ago

DEADLINE

in 13 days
View Details